progestin-only oral contraceptive pillsprogestogen - only pill (POP), the “minipill” - synthetic progestogen hormone, but no estrogenendometrial effects, progestogens - decreasing endometrial proliferationpharmacodynamics, synthetic progestogens - in POP...
POPs are associated with more breakthrough bleeding than COCs but fewer serious adverse events. Although not as well studied, POPs are thought to have many of the same non-contraceptive health benefits as COCs. 展开 关键词:progestin-only oral contraceptive pills progestogen - only pill (POP),...
ProgestinOnlyPills(POPs)I.INTRODUCTIONProgestinOnlyPills(POPs)containasynthetichormonemodeledafterthenaturallyoccurringhormoneprogesterone..
To reduce side effects of estrogen-progestin combination preparations, the dose of estrogen has continuously been reduced in the pill. As an alternative, estrogen-free preparations are increasingly used and are now available as oral, subdermal, intrauterine and intramuscular applications. The benefits ...
POPs are associated with more breakthrough bleeding than COCs but fewer serious adverse events. Although not as well studied, POPs are thought to have many of the same non-contraceptive health benefits as COCs. 展开 关键词:progestin‐only oral contraceptive pills progestogen ‐ only pill (POP)...
Recognition of the success of progestin-only methods, such as the hormonal IUDs, progestin dominant oral contraceptives, and the high dose progestin-only pill in substantially decreasing and controlling menstrual bleeding has led the way. This recognition also led to the development of many [non-...
The risks and benefits of new progestins used in contraception depend upon their molecular structure, the type and dose of associated estrogen, and the delivery route. The lower impact of E2-based combinations on metabolic surrogate markers may result in an improved safety profile, but only ...
Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: A prospective open-label comparative study. Acta Obstet. Gynecol. Scand. 2014, 93, 239–247. [Google Scholar] [CrossRef] Koga, K.; Takamura, M.;...